Jelikalite
JelikaLite is a clinical stage medical technology company developing a transformational neuromodulation platform for developmental pediatric disorders, with a primary focus on Autism Spectrum Disorder (ASD). Their lead product, Cognilum, is a therapeutic wearable device that uses near-infrared light, sensors, and a machine learning personalization platform to provide non-invasive brain stimulation. Cognilum aims to enhance communication skills and reduce autism symptoms in children, enabling them to lead more fulfilling lives. The company has received FDA Breakthrough Device Designation and FDA Non-Significant Risk Device Study Designation. JelikaLite has also been awarded a National Science Foundation SBIR Phase II grant to further develop their technology. Their approach is distinguished by being the first home-based LED-based device for children with autism, offering flexibility, privacy, and convenience without the need for in-person therapist presence.
Jelikalite
JelikaLite is a clinical stage medical technology company developing a transformational neuromodulation platform for developmental pediatric disorders, with a primary focus on Autism Spectrum Disorder (ASD). Their lead product, Cognilum, is a therapeutic wearable device that uses near-infrared light, sensors, and a machine learning personalization platform to provide non-invasive brain stimulation. Cognilum aims to enhance communication skills and reduce autism symptoms in children, enabling them to lead more fulfilling lives. The company has received FDA Breakthrough Device Designation and FDA Non-Significant Risk Device Study Designation. JelikaLite has also been awarded a National Science Foundation SBIR Phase II grant to further develop their technology. Their approach is distinguished by being the first home-based LED-based device for children with autism, offering flexibility, privacy, and convenience without the need for in-person therapist presence.